1차 출처 기록
FDA lists Zycubo (copper histidinate) as novel drug approval #1 of 2026 on 2026-01-12: To treat Menkes disease Drug Trials Snapshot
Fortress Biotech: FDA, CUTX-101 NDA에 대한 PDUFA 날짜를 2026년 1월 14일로 설정
Fortress Biotech: Sentynl, CUTX-101(Menkes disease) NDA 재제출
Fortress Biotech: FDA, CUTX-101 NDA에 CRL 발행